AN1 0.00% 0.8¢ anagenics limited

QBiotics v Cellmid

  1. 1,487 Posts.
    lightbulb Created with Sketch. 65
    Made from the north Queensland’s blushwood tree berries, QBiotics breakthrough cancer fighting EBC-46 drug for solid tumours has just received ethical approval for human trials.
    Until now, EBC-46 has been administered through veterinary clinics with demonstrations on TV tonight showing it's effects on dogs.


    Sound familiar?

    CDY has a product that produces better results on cancer then chemotherapy & in vetrinary testing (Zoetis in CDY's case).
    I see CDY's IP as having an advantage in that it will target small cancers that are not yet discovered to be injected with a syringe.


    Between this & CDY's recent results reversing osteoporosis, there should be a little more international & big pharma attention on small ozzie bio.
    Last edited by Trae: 15/08/16
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $3.690M
Open High Low Value Volume
0.9¢ 0.9¢ 0.8¢ $1.135K 134.3K

Buyers (Bids)

No. Vol. Price($)
2 214857 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 289915 2
View Market Depth
Last trade - 13.13pm 24/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.